Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0091-6749(99)70529-4PMID 9893189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells.

  1997cited by this paper
• NF-kappa B: a pivotal role in asthma and a new target for therapy.

  1997cited by this paper
• Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells.

  1997cited by this paper
• P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions.

  1997cited by this paper
• NF-kB: a pivotal role in asthma and a new target for therapy

  1997cited by this paper
• Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis.

  1997cited by this paper
• Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects.

  1997cited by this paper
• Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma.

  1996cited by this paper
• Interleukin 4 or oncostatin M induces a prolonged increase in P- selectin mRNA and protein in human endothelial cells

  1996cited by this paper
• Eosinophil apoptosis and the resolution of airway inflammation in asthma.

  1996cited by this paper
• Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids.

  1996cited by this paper
• A Sustained Reduction in IκB-β May Contribute to Persistent NF-κB Activation in Human Endothelial Cells*

  1996cited by this paper
• Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha.

  1996cited by this paper
• Postinduction transcriptional repression of E-selectin and vascular cell adhesion molecule-1.

  1996cited by this paper
• Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5.

  1996cited by this paper
• TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation.

  1995cited by this paper
• Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.

  1995cited by this paper
• Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells.

  1995cited by this paper
• Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps.

  1995cited by this paper
• IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells.

  1995cited by this paper
• Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

  1995cited by this paper
• Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent

  1994cited by this paper
• [Rhinitis and asthma].

  1994cited by this paper
• Nasal polyp inflammation. Effect of topical nasal steroid.

  1994cited by this paper
• Contribution of specific cell-adhesive glycoproteins to airway and alveolar inflammation and dysfunction.

  1993cited by this paper
• IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1.

  1992cited by this paper
• IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals.

  1992cited by this paper
• Interpretation and Uses of Medical Statistics

  1992cited by this paper
• Application of monoclonal antibodies against major basic protein (BMK‐13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma

  1992cited by this paper
• Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules

  1991cited by this paper
• Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor.

  1991cited by this paper
• Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.

  1991cited by this paper
• Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

  1991cited by this paper
• Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1.

  1991cited by this paper
• The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man.

  1988cited by this paper
• A clinical and pathologic study of chronic sinusitis: the role of the eosinophil.

  1988cited by this paper
• Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps.

  1988cited by this paper
• Recombinant human interleukin 5 is a selective activator of human eosinophil function

  1988cited by this paper
• Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

  1988cited by this paper
• Eosinophils cocultured with endothelial cells have increased survival and functional properties.

  1987cited by this paper
• Tissue localization of human eosinophil cationic proteins in allergic diseases.

  1985cited by this paper
• Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein

  1984cited by this paper
• Rhodium-102 High-Altitude Tracer Experiment: The tracer gives clues to the transport and distribution of materials in the stratosphere.

  1962cited by this paper

• Progress in cellular mechanisms of chronic rhinosinusitis

  2024cites this paper
• Effect of Systemic Prednisone Treatment on Changes of Inflammation Markers in Chronic Rhinosinusitis

  2023cites this paper
• The placebo effect in randomized‐controlled trials of medical treatments for chronic rhinosinusitis: A systematic review and meta‐analysis

  2023cites this paper
• Topical Corticosteroids for Chronic Rhinosinusitis with Nasal Polyposis: GRADE Systematic Review and Network Meta-Analysis.

  2022cites this paper
• Biology and Function of Eosinophils in Chronic Rhinosinusitis With or Without Nasal Polyps

  2020cites this paper
• Use of Nonmedicated Control Substances in Randomized Clinical Trials of Patients With Chronic Rhinosinusitis: A Systematic Review and Single-Arm Meta-analysis.

  2020cites this paper
• Evaluación de algunos parámetros inmunológicos y epidemiológicos en pacientes con poliposis nasal de localización etmoidal

  2018cites this paper
• Middle Meatal Antrostomy in Endoscopic Sinus Surgery

  2015cites this paper
• Steroids inhibit vascular endothelial growth factor expression via TLR4/Akt/NF-κB pathway in chronic rhinosinusitis with nasal polyp

  2014cites this paper
• Immune Imbalance in Nasal Polyps of Caucasian Chronic Rhinosinusitis Patients Is Associated with a Downregulation of E-Selectin

  2014cites this paper
• Effects of intranasal steroid treatment on the presence of biofilms in non-allergic patients with chronic rhinosinusitis with nasal polyposis

  2014cites this paper
• Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.

  2013cites this paper
• Pharmacological Management of Nasal Polyposis

  2012cites this paper
• Pharmacological and Other Interventions for Head and Neck Cancer Pain: a Systematic Review

  2012cites this paper
• Eosinophils in Human Disease

  2012cites this paper
• Sinonasal Masses: A Retrospective Analysis

  2012cites this paper
• Wirkmechanismen nasaler Glukokortikosteroide in der Therapie der allergischen Rhinitis

  2012cites this paper
• Evidence-Based Management of Nasal Polyposis by Intranasal Corticosteroids: From the Cause to the Clinic

  2011cites this paper
• Mast cell CRAC channel as a novel therapeutic target in allergy

  2011cites this paper
• MODERN MINIMALLY INVASIVE DIAGNOSTIC AND THERAPEUTIC OPTIONS FOR THE CHRONIC INFLAMMATION MEDIATED DISEASES OF THE AIRWAYS

  2010cites this paper
• Store-operated CRAC channels: function in health and disease

  2010cites this paper
• One-year evaluation of combined treatment with an intranasal corticosteroid and montelukast for chronic rhinosinusitis associated with asthma.

  2010cites this paper
• Narrow-band UVB phototherapy of nasal polyps: results of a pilot study.

  2010cites this paper
• Roles of vascular endothelial growth factor, Angiopoietin 1, and Angiopoietin 2 in nasal polyp

  2009cites this paper
• Glucocorticoid receptor immunoreactivity of eosinophils in nasal polyps

  2009cites this paper
• Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis

  2009cites this paper
• CRAC channels and Ca2+ signaling in mast cells

  2009cites this paper
• TGF-beta signaling and collagen deposition in chronic rhinosinusitis.

  2009cites this paper
• Surgical management of polyps in the treatment of nasal airway obstruction.

  2009cites this paper
• VCAM-1 and eosinophilia in diffuse sino-nasal polyps

  2009cites this paper
• Efficacy and safety of mometasone furoate nasal spray in allergic rhinitis, acute rhinosinusitis and nasal polyposis

  2009cites this paper
• Eosinophil infiltration of nasal polyps in patients with nasal polyposis: role in clinical evolution after medical and surgical treatment.

  2009cites this paper
• Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis.

  2009cites this paper
• The effect of macrolides on allergic rhinitis versus chronic rhinosinusitis – An in vitro study

  2008cites this paper
• The role of steroid injection in the management of sinonasal polyps

  2008cites this paper
• Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids

  2008cites this paper
• The Anti-inflammatory Effect of Macrolide Antibiotics in Chronic Rhinosinusitis

  2007cites this paper
• Nasal polyp diseases in allergic and nonallergic patients and steroid therapy

  2006cites this paper
• Inhibition of Tumor Necrosis Factor α for Refractory Asthma

  2006cites this paper
• Topical furosemide versus oral steroid in preoperative management of nasal polyposis

  2006cites this paper
• Topical steroids do not downregulate expression of growth-related oncogene-α in nasal polyps

  2006cites this paper
• Rhinosinusitis: Developing guidance for clinical trials

  2006cites this paper
• The effect of transforming growth factor (TGF)-β1 and (TGF)-β2 on nasal polyp fibroblast activities involved upper airway remodeling: Modulation by fluticasone propionate

  2006cites this paper
• Targeting memory Th2 cells for the treatment of allergic asthma.

  2006cites this paper
• Inhibition of tumor necrosis factor alpha for refractory asthma.

  2006cites this paper
• Intranasal Corticosteroids for Nasal Polyposis

  2006cites this paper
• Tumour necrosis factor-α as a therapeutic target in asthma

  2006cites this paper
• The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate.

  2006cites this paper
• Rhinosinusitis: Developing guidance for clinical trials.

  2006cites this paper
• TNF-α as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis

  2005cites this paper
• Effect of inhaled corticosteroid on an immunoreactive thymus and activation‐regulated chemokine expression in the bronchial biopsies from asthmatics

  2005cites this paper
• Endothelial L-selectin ligands in sinus mucosa during chronic maxillary rhinosinusitis.

  2005cites this paper
• Pathophysiological effects of glucocorticoids on nasal polyps: an update

  2005cites this paper
• TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis.

  2005cites this paper
• Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps

  2004influential citation
• Inhaled glucocorticoids, lymphocytes, and dendritic cells in asthma and obstructive lung diseases.

  2004cites this paper
• Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps.

  2004cites this paper
• Adhesion molecules as therapeutic targets.

  2004cites this paper
• Prognostische und pathophysiologische Faktoren der chronischen Nasennebenhöhlenentzündung

  2004cites this paper
• Measurement of quality of life during different clinical phases of Japanese cedar pollinosis.

  2004cites this paper
• Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis.

  2004cites this paper
• Rhinosinusitis: Establishing definitions for clinical research and patient care

  2004cites this paper
• IL‐11 and IL‐17 expression in nasal polyps: Relationship to collagen deposition and suppression by intranasal fluticasone propionate

  2003cites this paper
• Chronic ‘Immunological’ Rhinosinusitis: General Aspects, Cytokines, Chemokines and Possible Therapeutic Consequences

  2003cites this paper
• Role of cytokines in nasal polyposis.

  2003cites this paper
• Interleukin (IL)‐4 and to a lesser extent either IL‐13 or interferon‐gamma regulate the production of eotaxin‐2/CCL24 in nasal polyps

  2003cites this paper
• P‐selectin mediates IL‐13‐induced eosinophil transmigration but not eotaxin generation in vivo: a comparative study with IL‐4‐elicited responses

  2003cites this paper
• Acute Community-Acquired Rhinosinusitis

  2003cites this paper
• In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytes.

  2002cites this paper
• Cytokines in nasal lavage fluids from acute sinusitis, allergic rhinitis, and chronic fatigue syndrome subjects.

  2002cites this paper
• Fluticasone Propionate Downregulates Nasal Fibroblast Functions Involved in Airway Inflammation and Remodeling

  2002cites this paper
• Modulation of TNF and GM-CSF release from dispersed human nasal polyp cells and human whole blood by inhibitors of different PDE isoenzymes and glucocorticoids.

  2002cites this paper
• Pharmacological treatments for rhinosinusitis

  2002cites this paper
• [Pharmacology of glucocorticoids and ENT pathology].

  2001cites this paper
• Eosinophil trafficking in asthma.

  2001cites this paper
• Medical and surgical management of nasal polyps

  2001cites this paper
• The microbiology and management of acute and chronic rhinosinusitis

  2001cites this paper
• Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment

  2001cites this paper
• Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 Gene Expressions and Their Differential Regulation by Proinflammatory Cytokines and Prostaglandin in Nasal Polyp Fibroblasts

  2001cites this paper
• The role of medical management in rhinosinusitis

  2001cites this paper
• Clinical Significance of Rhinosinusitis in Severe Asthma and Its Management

  2001cites this paper
• GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.

  2001cites this paper
• Studies on the molecular basis of eosinophil adhesion to endothelium

  2001cites this paper
• Nasal Polyposis: From Cytokines to Growth

  2000cites this paper
• Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-γ, IL-1β, TNF-α, or neutrophils☆☆☆

  2000cites this paper
• Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.

  2000cites this paper
• Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow.

  2000cites this paper
• The role of adhesion in eosinophil function.

  2000cites this paper
• Maximal medical management of chronic rhinosinusitis

  2000cites this paper
• Chronic sinusitis.

  2000cites this paper
• Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.

  1999cites this paper
• CORTICOSTEROIDS IN THE TREATMENT OF SINUSITIS AND NASAL POLYPS

  1999cites this paper
• Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm.

  1999cites this paper
• Pharmacotherapy to prevent the complications of allergic rhinitis.

  1999cites this paper
• Airway Inflammation with Eosinophilia Monocyte-Chemotactic Protein-4 in Human Expression for Eotaxin, Eotaxin-2, and Glucocorticosteroids Inhibit mRNA

  1999cites this paper